Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization

The rapid transmission of SARS-CoV-2 in the USA and worldwide necessitates the development of multiple vaccines to combat the COVID-19 global pandemic. Previously, we showed that a particulate adjuvant system, quil-A-loaded chitosan (QAC) nanoparticles, can elicit robust immunity combined with plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrasekar, Shaswath S., Phanse, Yashdeep, Hildebrand, Rachel E., Hanafy, Mostafa, Wu, Chia-Wei, Hansen, Chungyi H., Osorio, Jorge E., Suresh, M., Talaat, Adel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914464/
https://www.ncbi.nlm.nih.gov/pubmed/33562141
http://dx.doi.org/10.3390/vaccines9020132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914464/
https://www.ncbi.nlm.nih.gov/pubmed/33562141
http://dx.doi.org/10.3390/vaccines9020132

Ejemplares similares